Vikobi Premium Tablets

Adult dose

For individuals 12 years old and older, take 1 tablet once a day.

This medication should not be taken by patients with hypercalcemia, sarcoidosis (a systemic inflammatory disease of unknown cause), or those with kidney disease. Additionally, individuals who have had allergic reactions to the components of this medicine, infants under 12 months, patients with kidney stones or severe renal failure, or those allergic to soybean oil, soy, or peanuts should also avoid taking it. It is important not to take this medicine together with phosphates, calcium salts, oral tetracycline antibiotics, antacids, and drugs like levodopa during treatment. If receiving medical care, or if there are issues with oxalate metabolism, peptic ulcers, heart or kidney function, or in pregnant or breastfeeding women, professional consultation is necessary before use. If symptoms of nausea, vomiting, diarrhea, skin rash, loss of appetite, abdominal bloating, irregular heartbeats, central nervous system symptoms, hair loss, hypotension, or pulmonary edema occur during use, stop taking it immediately and consult a professional. Additionally, if there are changes in menstruation or prolonged bleeding, long-term high-dose use may lead to tolerance, and certain vitamin supplements may cause neurological or blood abnormalities. This medication must be taken according to the prescribed dosage and administration, and when taken by children, parental supervision is required. During use, inform healthcare personnel as it may affect blood glucose testing or clinical evaluations, and avoid teas containing tannins, such as green tea or black tea, before and after use. Patients at risk of lipid overload should regularly check blood lipid levels, and if using other lipid injections, lipid amounts must be adjusted. Finally, this medication should be stored out of reach of children, kept in a cool, dry place away from direct sunlight, and should not be transferred to other containers to maintain quality.

Serious side effects

Rash, erythema (redness and swelling), tachycardia (irregular heartbeat), central nervous system depression, pulmonary edema (swelling), increased risk of thrombosis, sensory neuropathy or neurological symptoms, hematological adverse reactions, peptic ulcer, liver damage, congestive heart failure, edema

Mild side effects

Nausea, vomiting, diarrhea, abdominal discomfort, constipation, rash, erythema (redness and swelling), loose stools, loss of appetite, abdominal bloating, red spots, tachycardia (irregular heartbeat), central nervous system depression, dermatitis, odor during sweating and breathing, hair loss, agitation, gastrointestinal disorders, digestive disorders, upper abdominal pain, hypotension, pulmonary edema (swelling), changes in menstruation, increased risk of thrombosis, sensory neuropathy or neurological symptoms, hematological adverse reactions

This medication should be stored in a sealed container that allows for adequate air circulation, kept at room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medicine can be maintained for a longer time.

Appearance

Brown oblong film-coated tablets

Package unit

60 tablets/bottle, 120 tablets/box[(60 tablets/bottle *2)]